-
Arimoclomol, sold
under the
brand name Miplyffa, is a
medication for the
treatment of Niemann–Pick
disease type C. It is
taken by mouth. The most common...
-
Jefferson University Lysosomal Disease Testing Lab and the Mayo Clinic.
Arimoclomol, sold
under the
brand name Miplyffa, is a
medication for the treatment...
- alfa (Xenpozyme) was
approved for
medical use in ****an in
March 2022.
Arimoclomol (Miplyffa) was
approved for
medical use in the
United States in September...
- N07XX14
Edaravone N07XX15
Inotersen N07XX16 Deutetrabe****ne N07XX17
Arimoclomol N07XX18
Vutrisiran N07XX19
Sodium phenylbutyrate and ursodoxicoltaurine...
- lost over half of its
share value overnight upon
disclosing a CRL for
arimoclomol, a
proposed treatment for Niemann–Pick disease, type C,
forcing the company...
-
Argyrol S.S.
arhalofenate (USAN, INN)
Aricept arildone (INN)
Arimidex Arimoclomol aripiprazole (INN)
Aristocort Aristogel Aristospan Arixtra Arlex Arlidin...
- acid,
lithium carbonate, pioglitazone, Ono-2506 (arundic acid), and
arimoclomol.
Repetitive transcranial magnetic stimulation had been
studied in amyotrophic...
